Cargando…
Hydroxychloroquine and Fabry Disease: Three Case Reports Examining an Unexpected Pathologic Link and a Review of the Literature
BACKGROUND: Hydroxychloroquine is an effective and widely used treatment in multiple autoimmune connective tissue diseases that gained a lot of publicity in the coronavirus disease 2019 (COVID-19) pandemic. Our case reports are unique in that they explore the rare and sometimes overlooked effects of...
Autores principales: | Sen, Rouhin, Borghoff, Kathleen, Foster, Kirk W., Radio, Stanley J., Erickson, Alan, Hearth-Holmes, Michelene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293550/ https://www.ncbi.nlm.nih.gov/pubmed/35860433 http://dx.doi.org/10.1155/2022/2930103 |
Ejemplares similares
-
Curvilinear bodies in hydroxychloroquine-induced renal phospholipidosis resembling Fabry disease
por: Costa, Rui M., et al.
Publicado: (2013) -
Lupus Nephritis and Hydroxychloroquine-Associated Zebra Bodies: Not Just in Fabry Disease
por: Manabe, Shun, et al.
Publicado: (2021) -
Does administration of hydroxychloroquine/amiodarone accelerate accumulation of globotriaosylceramide and globotriaosylsphingosine in Fabry mice?
por: Tsukimura, Takahiro, et al.
Publicado: (2021) -
Unexpectedly high renal pathological scores of two female siblings with Fabry disease presenting with urinary mulberry cells without microalbuminuria
por: Yamada, Natsuo, et al.
Publicado: (2022) -
An Atypical Cardiac Manifestation of Fabry Disease from a Novel Pathological Variant on the GLA Gene
por: Sarsam, Luay, et al.
Publicado: (2020)